Developments in understanding migraine pathogenesis and, in particular, the role of the neuropeptide, calcitonin gene-related peptide (CGRP), have led to breakthroughs which will revolutionise treatment, especially chronic migraine (defined conventionally as over 15 headache days a month).
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.